收稿日期: 2018-08-10
网络出版日期: 2020-12-13
基金资助
兰州大学第一医院院内基金(ldyyyn2014-14)
高鹏 , 雒艳萍 , 李俊峰 . B/C基因型的乙型肝炎病毒对不同免疫阶段慢性乙型肝炎患者T淋巴细胞及其亚群的影响[J]. 北京大学学报（医学版）, 2020 , 52(6) : 1153 -1156 . DOI: 10.19723/j.issn.1671-167X.2020.06.029
| [1] | 中华医学会传染病学会肝病分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2010,12(6):324-326. |
| [2] | Lin CL, Kao JH. Hepatitis B virus genotypes: Clinical relevance and therapeutic implications[J]. Curr Hepat Rep, 2013,12(2):124-132. |
| [3] | Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances[J]. J Gastroenterol Hepatol, 2011,26(Suppl 1):123-130. |
| [4] | Busch K, Thimme R. Natural history of chronic hepatitis B virus infection[J]. Med Microbiol Immunol, 2015,204(1):5-10. |
| [5] | Burns GS, Thompson AJ. Viral hepatitis B: Clinical and epidemiological characteristics[J]. Cold Spring Harb Perspect Med, 2014,4(12):1101-1112. |
| [6] | Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship[J]. World J Gastroenterol, 2014,20(30):10395-10404. |
| [7] | Kandilarova SM, Georgieva AI. Immune cell subsets evaluation as a predictive tool for hepatitis B infection outcome and treatment responsiveness[J]. Folia Med, 2017,59(1):53-62. |
| [8] | Lok AS, Zoulim F. Hepatitis B cure: From discovery to regulatory approval[J]. J Hepatol, 2017,66(4):847-861. |
| [9] | Bertoletti A, Ferrari C. Adaptive immunity in HBV infection[J]. J Hepatol, 2016,64(Suppl 1):71-77. |
| [10] | Park JJ, Wong DK. Hepatitis B virus: specific and global T-cell dysfunction in chronic hepatitis B[J]. Gastroenterology, 2016,150(3):684-695. |
| [11] | Liu Y, Cheng LS. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection[J]. Clin Sci (Lond), 2016,130(11):907-919. |
| [12] | Dinney CM, Zhao LD. Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection[J]. J Microbiol, 2015,53(10):718-724. |
/
| 〈 |
|
〉 |
